(PGJ) Golden Dragon China - Overview
Etf: Technology, Consumer Discretionary, Communication Services
Dividends
| Dividend Yield | 3.16% |
| Yield on Cost 5y | 1.39% |
| Yield CAGR 5y | 61.97% |
| Payout Consistency | 77.9% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.4% |
| Relative Tail Risk | -8.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.34 |
| Alpha | -0.14 |
| Character TTM | |
|---|---|
| Beta | 0.796 |
| Beta Downside | 0.869 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.82% |
| CAGR/Max DD | 0.09 |
Description: PGJ Golden Dragon China January 17, 2026
The Invesco Golden Dragon China ETF (NASDAQ: PGJ) is a U.S.-registered fund that commits at least 90 % of its net assets to the securities that constitute its benchmark index, which tracks U.S.-listed companies that are headquartered or incorporated in the People’s Republic of China. Because the index is relatively concentrated, the ETF is classified as non-diversified under SEC rules.
As of the most recent filing (Q4 2025), PGJ reported approximately $1.2 billion in assets under management with an expense ratio of 0.55 % (source: Invesco fund factsheet). The top sector exposures are technology (≈ 38 % of assets), consumer discretionary (≈ 22 %) and industrials (≈ 15 %), reflecting China’s continued emphasis on digital infrastructure and domestic consumption. A key macro driver is China’s GDP growth, which the IMF projects at 4.6 % for 2025, but this figure is highly sensitive to policy shifts around property sector deleveraging and export demand. Any escalation in U.S.–China regulatory friction could materially affect the fund’s performance, especially given its reliance on U.S.-listed Chinese ADRs.
For a deeper, data-driven analysis of PGJ’s risk-adjusted returns and sector tilt, you may find it useful to explore the ValueRay platform, which aggregates real-time metrics and peer comparisons.
What is the price of PGJ shares?
Over the past week, the price has changed by +0.98%, over one month by -0.27%, over three months by -3.86% and over the past year by +10.20%.
Is PGJ a buy, sell or hold?
What are the forecasts/targets for the PGJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31.6 | 5.7% |
PGJ Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 139.3m USD (139.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 139.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 139.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.85% (E(139.3m)/V(139.3m) * Re(8.85%) + (debt-free company))
Discount Rate = 8.85% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)